MetaCap

Shattuck Labs Inc. Company Profile

NASDAQ: STTKHealth CareBiotechnology: Pharmaceutical PreparationsUSD

4.46-0.09 (-1.98%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Shattuck Labs at a glance

Shattuck Labs Inc. (NASDAQ: STTK) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Austin, TX. Shattuck Labs is led by Dr. Taylor H. Schreiber M.D., Ph.D. and employs about 40 people. The company's shares have traded publicly since 2020.

At a market capitalization of $463.4 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001680367, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Shattuck Labs do?

Shattuck Labs, Inc., a clinical-stage biotechnology company, engages in the development of antibodies for the treatment of inflammatory and immune-mediated diseases in the United States. The company develops SL-325, a death receptor 3 blocking monoclonal antibody, which is in Phase I clinical trial for the treatment of tumor necrosis factor like ligand 1A; and SL-425, a half-life extended version of SL-325, which is under IND-enabling chronic good laboratory practices toxicity study. It is also involved in the development of various preclinical DR3-based bispecific antibodies for the treatment of patients with inflammatory bowel disease or other immune-mediated indications; and TRIM7, an oncology-focused program. The company was incorporated in 2016 and is headquartered in Austin, Texas.

Business description based on the company's public filings.

Company information

Legal name
Shattuck Labs Inc.
Ticker
NASDAQ: STTK
Industry
Biotechnology: Pharmaceutical Preparations
CEO
Dr. Taylor H. Schreiber M.D., Ph.D.
Employees
40
Headquarters
500 West 5th Street, Austin, TX, United States
Phone
512 900 4690
IPO year
2020
Market cap
$463.38M
SEC CIK
0001680367
Latest annual report
10-K · Mar 5, 2026

Companies similar to Shattuck Labs

STTK peer companies
CompanyPrice% ChgMarket capCompare
BLSMBlossomHill Therapeutics Inc.14.51+0.69%$461.20Mvs STTK
RZLTRezolute Inc.3.92-6.67%$465.58Mvs STTK
GYREGyre Therapeutics Inc.4.21-6.86%$460.79Mvs STTK
MNPRMonopar Therapeutics Inc.69.00-1.84%$467.60Mvs STTK
NGNENeurogene Inc.22.15-3.40%$458.53Mvs STTK
EVOEvotec SE ADR1.32-8.97%$469.11Mvs STTK
ASMBAssembly Biosciences Inc.22.19-1.38%$454.39Mvs STTK
KMDAKamada Ltd.7.74-1.15%$446.85Mvs STTK

Related